Becton, Dickinson and Company
Capitalización de mercado
$49.6B
Puesto mundial
#263
Máximo histórico
$51.5B
2019-12-31
Crecimiento total
+0%
desde 2026
Market Cap Context
- Larger than 28% of the 367 companies we track (globally).
- Equivalent to 0.2% of United States's GDP (2025 data).
- Just above: #262 United Overseas Bank Limited ($50.2B)
- Just below: #264 BASF SE ($48.2B)
- Best year: 1998 (+72%). Worst year: 1999 (-36%).
Becton, Dickinson and Company Financial Breakdown (FY 2025)
Source: Yahoo Finance — BDX annual filings (2025) →$21.8B revenue · $3.0B operating income · $1.7B net income
- ●Operating margin: 13.7% on $21.8B in revenue.
- ●R&D is 5.8% of revenue ($1.3B).
- ●Net income margin: 7.7% — $1.7B in profit.
- ●Free cash flow: $2.7B (12.2% of revenue).
Cost / Operating Expenses
Total operating expenses $18.9B
Total
$18.5B
Capital Expenditures
$0.8B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$2.7B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Acerca de Becton, Dickinson and Company
Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.
Historial de capitalización de mercado de Becton, Dickinson and Company (2026–2026)
Becton, Dickinson and Company vs Sector Peers by Market Cap
Comparar Becton, Dickinson and Company
Historial de clasificación
| Año | Capitalización de mercado | Puesto | Variación interanual |
|---|---|---|---|
| 2026 | $49.6B | #263(↑10) | +20.2% |
| 2025 | $41.3B | #273(↓29) | -12.7% |
| 2024 | $47.2B | #244(↓21) | -5.4% |
| 2023 | $50.0B | #223(↓48) | -2.7% |
| 2022 | $51.3B | #175(↑34) | +5.1% |
| 2021 | $48.9B | #209(↓29) | +1.9% |
| 2020 | $48.0B | #180(↓43) | -6.8% |
| 2019 | $51.5B | #137(↓10) | +22.2% |
| 2018 | $42.1B | #127(↑16) | +6.6% |
| 2017 | $39.5B | #143(↑8) | +31.4% |
| 2016 | $30.1B | #151(↓5) | +9.2% |
| 2015 | $27.5B | #146(↑13) | +12.6% |
| 2014 | $24.4B | #159(↑14) | +28.4% |
| 2013 | $19.0B | #173(↑8) | +44.5% |
| 2012 | $13.2B | #181(↓15) | +7.2% |
| 2011 | $12.3B | #166(↓12) | -9.8% |
| 2010 | $13.6B | #154(↓1) | +9.4% |
| 2009 | $12.5B | #153(↓26) | +17.7% |
| 2008 | $10.6B | #127(↑30) | -17.1% |
| 2007 | $12.8B | #157(↑6) | +20.7% |
| 2006 | $10.6B | #163(↓4) | +18.4% |
| 2005 | $8.9B | #159(↓12) | +7.1% |
| 2004 | $8.3B | #147(↑13) | +39.9% |
| 2003 | $6.0B | #160(↓4) | +35.6% |
| 2002 | $4.4B | #156(↑8) | -6.3% |
| 2001 | $4.7B | #164(↓15) | -3.2% |
| 2000 | $4.9B | #149(↓19) | +30.2% |
| 1999 | $3.7B | #130(↓42) | -36.3% |
| 1998 | $5.8B | #88(↑25) | +72.3% |
| 1997 | $3.4B | #113(↓9) | +16.7% |
| 1996 | $2.9B | #104(↓10) | +17.0% |
| 1995 | $2.5B | #94(↓4) | +58.6% |
| 1994 | $1.6B | #90 |
Otras empresas del sector Salud
Preguntas frecuentes
What is Becton, Dickinson and Company's market cap?
Becton, Dickinson and Company (BDX) has a market capitalization of $49.6B, making it the #263 largest company in the world by market cap.
What was Becton, Dickinson and Company's highest market cap?
Becton, Dickinson and Company's all-time high market cap was $51.5B, reached in 2019-12-31. Its highest rank was #137 in 2019.
What sector is Becton, Dickinson and Company in?
Becton, Dickinson and Company is in the Healthcare sector, specifically the Medical Instruments & Supplies industry. It is based in United States.
How has Becton, Dickinson and Company's market cap changed over time?
Becton, Dickinson and Company has been tracked since 2026. Its market cap has grown by 0% from $49.6B in 2026 to $49.6B today.